DE69507017D1 - Cai-resistenzproteine kodierende dna, und ihre verwendung - Google Patents

Cai-resistenzproteine kodierende dna, und ihre verwendung

Info

Publication number
DE69507017D1
DE69507017D1 DE69507017T DE69507017T DE69507017D1 DE 69507017 D1 DE69507017 D1 DE 69507017D1 DE 69507017 T DE69507017 T DE 69507017T DE 69507017 T DE69507017 T DE 69507017T DE 69507017 D1 DE69507017 D1 DE 69507017D1
Authority
DE
Germany
Prior art keywords
cai
encoding dna
resistance proteins
proteins encoding
cai resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69507017T
Other languages
English (en)
Other versions
DE69507017T2 (de
Inventor
Elise C Kohn
Lance A Liotta
Young Sook Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of DE69507017D1 publication Critical patent/DE69507017D1/de
Application granted granted Critical
Publication of DE69507017T2 publication Critical patent/DE69507017T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
DE69507017T 1994-03-14 1995-03-14 Cai-resistenzproteine kodierende dna, und ihre verwendung Expired - Fee Related DE69507017T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/212,190 US5652223A (en) 1994-03-14 1994-03-14 DNA encoding CAI resistance proteins and uses thereof
PCT/US1995/003610 WO1995025125A1 (en) 1994-03-14 1995-03-14 Dna encoding cai resistance proteins and uses thereof

Publications (2)

Publication Number Publication Date
DE69507017D1 true DE69507017D1 (de) 1999-02-11
DE69507017T2 DE69507017T2 (de) 1999-08-12

Family

ID=22789940

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69507017T Expired - Fee Related DE69507017T2 (de) 1994-03-14 1995-03-14 Cai-resistenzproteine kodierende dna, und ihre verwendung

Country Status (11)

Country Link
US (2) US5652223A (de)
EP (1) EP0750637B1 (de)
JP (1) JPH09511236A (de)
AT (1) ATE175212T1 (de)
AU (1) AU684930B2 (de)
CA (1) CA2185341A1 (de)
DE (1) DE69507017T2 (de)
DK (1) DK0750637T3 (de)
ES (1) ES2128048T3 (de)
GR (1) GR3029811T3 (de)
WO (1) WO1995025125A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652223A (en) * 1994-03-14 1997-07-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services DNA encoding CAI resistance proteins and uses thereof
US6790936B1 (en) 1994-03-14 2004-09-14 The United States Of America As Represented By The Department Of Health And Human Services CAI resistance proteins and uses thereof
WO2000014106A1 (en) * 1998-09-09 2000-03-16 The Burnham Institute Novel bag proteins and nucleic acid molecules encoding them
US6696558B2 (en) * 1998-09-09 2004-02-24 The Burnham Institute Bag proteins and nucleic acid molecules encoding them
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
EP1323733A1 (de) * 2001-12-28 2003-07-02 Arturo Leone BAG3-Nukleotid- und Proteinsequenzen zur Nutzung in Forschung, Diagnose und der Behandlung von Krankheiten, an denen Zelltod beteiligt ist
US7517697B2 (en) * 2003-02-05 2009-04-14 Applied Biosystems, Llc Compositions and methods for preserving RNA in biological samples
EP2011882B1 (de) 2006-05-02 2012-03-28 Teikyo University Verfahren zum screenen auf eine substanz, die glutathion erhöhen kann
EP2676966A1 (de) * 2012-06-19 2013-12-25 Biouniversa S.r.l. BAG3 als biochemisches Serum und Gewebemarker

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359078A (en) * 1989-05-19 1994-10-25 The United States Of America As Represented By The Department Of Health And Human Services Signal transduction inhibitor compounds
US5652223A (en) * 1994-03-14 1997-07-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services DNA encoding CAI resistance proteins and uses thereof

Also Published As

Publication number Publication date
DK0750637T3 (da) 1999-08-30
ATE175212T1 (de) 1999-01-15
GR3029811T3 (en) 1999-06-30
US5652223A (en) 1997-07-29
JPH09511236A (ja) 1997-11-11
EP0750637A1 (de) 1997-01-02
EP0750637B1 (de) 1998-12-30
CA2185341A1 (en) 1995-09-21
WO1995025125A1 (en) 1995-09-21
DE69507017T2 (de) 1999-08-12
AU684930B2 (en) 1998-01-08
US5981712A (en) 1999-11-09
ES2128048T3 (es) 1999-05-01
AU2126395A (en) 1995-10-03

Similar Documents

Publication Publication Date Title
DE122010000023I2 (de) IL-1 Rezeptor Fusionsproteine verwendet als Antagoniste und Verfahren zu deren Verwendung und Herstellung.
DE69635482D1 (de) Säugetieren apoptosis inhibitorprotein genfamilie, primers, probes und verfahren zur nachweis
AU6380001A (en) Porous ferro- or ferrimagnetic glass particles for isolating molecules
ATE435280T1 (de) Methode zur isolierung von dna aus biologischen materialien
EP1687283A4 (de) Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung
DE69939945D1 (de) Verfahren zur isolierung von stammzellen
EP0188450A4 (de) Verfahren zum in vitro-nachweis und bestimmung unbekannter pathogene oder genetischer einheiten.
DE69434614D1 (de) Cdn apoptosis modulierende proteine, sie kodierende dns und verfahren zu ihrer verwendung
ATE454468T1 (de) Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose
DE69507017T2 (de) Cai-resistenzproteine kodierende dna, und ihre verwendung
ATE173544T1 (de) Parvovirusrezeptoren und verfahren zur ihrer verwendung
ATE319814T1 (de) Luciferase, fluoreszenzproteine, für luciferase und fluoreszenzproteine kodierend nukleinsaüre und ihre verwendung in der diagnose, hoch- durchsatz screeningsverfahren
ATE239274T1 (de) Proteom-analyse zum charakterisieren von auf- und abgeregelten proteinen in biologischen proben
DE69826493D1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
SI1465927T1 (sl) Protitelesa proti BAG3 za uporabo pri raziskavi, diagnostiki in terapiji bolezni, ki vključujejo celično smrt
DK1051491T3 (da) Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf
ATE166395T1 (de) Für c.difficile spezifische oligonukleotide
CA2273855A1 (en) Novel feline fc epsilon receptor alpha chain nucleic acid molecules, proteins and uses thereof
ATE286984T1 (de) Methode und testsatz zur detektion von schistosomiasis mittels polymerasekettenreaktion
DE60221550D1 (de) Methode zur bestimmung der zellzyklusposition
CA2331742A1 (en) Methods for quantitating low level modifications of nucleotide sequences
ATE361367T1 (de) Zusammensetzungen mit fusionsproteinen der kinase wee1, nukleotidsequenzen, expressionsysteme und verfahren zu deren verwendung
DK1423708T3 (da) Sammensætninger og fremgangsmåder til bestemmelser af AA4RP
WO2000006733A3 (en) T cell receptor proteins, nucleic acid molecules, and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee